KUCHARCHUK ANDREW ALBERT
Transaction: 08/03/2025
OTHER
Change
0
Price
Not reported
Filing
08/05/2025
Type
OTHER
Windtree Therapeutics, Inc.
WINT • Biotechnology
$0.00
— 0.00 (0.00%)
Current price
EarningsLatest report: Sep 30, 2025
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$8.003
Growth
-100.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.18Weak liquidity · 0.45Weak profitability
Financial data as of: Sep 30, 2025, 12:00 AM UTCLast earnings update: Nov 19, 2025, 12:00 AM UTCLast profile update: Sep 2, 2026, 12:20 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.00
Change0.00%
Shares Out26.68K
Market Cap$8.00
Enterprise Value$11.94M
Beta1.60
P/E-0.00
P/S0.00
P/B-0.00
P/FCF-0.00
EV/Sales132.67
EV/EBITDA-0.28
Price$0.00
Change0.00%
Shares Out26.68K
Market Cap$8.00
Enterprise Value$11.94M
Beta1.60
P/E-0.00
P/S0.00
P/B-0.00
P/FCF-0.00
EV/Sales132.67
EV/EBITDA-0.28
EV/FCF-0.79
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.18
Current Ratio0.45
Quick Ratio0.45
Revenue 5Y-100.00%
Volume70.00K
Avg Volume106.86K
EPS Surprise95.94
Investment DNA
How strong this company looks for long-term investors
43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
39/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0.18Weak liquidity · 0.45Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 5 analyst votes · 2026-09-05
80/100
Bullish
Bullish
3
Hold
2
Bearish
0
Insider Transactions
Recent executive and insider activity
Kelly Leanne
Transaction: 01/08/2025
OTHER
Change
0
Price
Not reported
Filing
01/14/2025
Type
OTHER
Fraser Craig
Transaction: 10/08/2024
BUY
Change
+5,431
Price
$0.91
Filing
10/09/2024
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| KUCHARCHUK ANDREW ALBERT | OTHER | 0 | Not reported | 08/03/2025 | 08/05/2025 |
| Kelly Leanne | OTHER | 0 | Not reported | 01/08/2025 | 01/14/2025 |
| Fraser Craig | BUY | +5,431 | $0.91 | 10/08/2024 | 10/09/2024 |
| Latkin Jed | OTHER | 0 | Not reported | 08/13/2024 | 08/14/2024 |
| PELLETIER SAUNDRA L | OTHER | 0 | Not reported | 08/13/2024 | 08/14/2024 |
| Fraser Craig | BUY | +19 | Not reported | 07/22/2024 | 07/24/2024 |
| Fraser Craig | BUY | +4,011 | $4.11 | 07/22/2024 | 07/24/2024 |
| Simonson Steven | BUY | +13 | Not reported | 07/22/2024 | 07/24/2024 |
| Simonson Steven | BUY | +2,674 | $4.11 | 07/22/2024 | 07/24/2024 |
| Fraser Craig | BUY | +2,500 | $1.02 | 09/27/2023 | 09/28/2023 |
| Fraser Craig | BUY | +2,500 | $0.90 | 09/26/2023 | 09/27/2023 |
| McAndrew Jamie | SELL | -15,000 | $1.21 | 08/24/2023 | 09/05/2023 |
| McAndrew Jamie | OPTION | 0 | Not reported | 08/24/2023 | 09/05/2023 |
| Geffken Daniel E. | BUY | +2,033 | Not reported | 08/23/2023 | 08/29/2023 |
| Geffken Daniel E. | BUY | +3,050 | $1.21 | 08/23/2023 | 08/29/2023 |
| Fraser Craig | BUY | +45,867 | Not reported | 08/23/2023 | 08/25/2023 |
| Fraser Craig | BUY | +68,800 | $1.21 | 08/23/2023 | 08/25/2023 |
| Curtis Eric | BUY | +14,667 | Not reported | 08/23/2023 | 08/25/2023 |
| Curtis Eric | BUY | +22,000 | $1.21 | 08/23/2023 | 08/25/2023 |
| Simonson Steven | BUY | +15,867 | Not reported | 08/23/2023 | 08/25/2023 |